Evidence map›Paper›PMID 30108739›Full record

ArticleMedChemComm2017

Identification of novel

Shourong Liu, Yanmei Zhao, Ruoyu He, Limin Kong, Jianjun Xi, Jingjing Sun, Yidan Shao, Xuwang Pan, Jiankang Zhang, Rangxiao Zhuang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MedChemComm, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Shourong LiuDepartment of Pharmaceutical Preparation , Hangzhou Xixi Hospital , Hangzhou 310023 , Zhejiang Province , China . Email: zhuangrangxiao@sina.com ; Email: zjk0125@yeah.net ; ; Fax: +86 571 8546 3955 ; Tel: +86 571 8648 1960.
Yanmei ZhaoDepartment of Pharmaceutical Preparation , Hangzhou Xixi Hospital , Hangzhou 310023 , Zhejiang Province , China . Email: zhuangrangxiao@sina.com ; Email: zjk0125@yeah.net ; ; Fax: +86 571 8546 3955 ; Tel: +86 571 8648 1960.ORCID 0000-0001-8880-0376
Ruoyu HeDepartment of Pharmaceutical Preparation , Hangzhou Xixi Hospital , Hangzhou 310023 , Zhejiang Province , China . Email: zhuangrangxiao@sina.com ; Email: zjk0125@yeah.net ; ; Fax: +86 571 8546 3955 ; Tel: +86 571 8648 1960.
Limin KongDepartment of Pharmacy , The First Affiliated Hospital , College of Medicine , Zhejiang University , Hangzhou 310003 , Zhejiang Province , China.
Jianjun XiDepartment of Pharmaceutical Preparation , Hangzhou Xixi Hospital , Hangzhou 310023 , Zhejiang Province , China . Email: zhuangrangxiao@sina.com ; Email: zjk0125@yeah.net ; ; Fax: +86 571 8546 3955 ; Tel: +86 571 8648 1960.
Jingjing SunDepartment of Pharmaceutical Preparation , Hangzhou Xixi Hospital , Hangzhou 310023 , Zhejiang Province , China . Email: zhuangrangxiao@sina.com ; Email: zjk0125@yeah.net ; ; Fax: +86 571 8546 3955 ; Tel: +86 571 8648 1960.
Yidan ShaoDepartment of Pharmaceutical Preparation , Hangzhou Xixi Hospital , Hangzhou 310023 , Zhejiang Province , China . Email: zhuangrangxiao@sina.com ; Email: zjk0125@yeah.net ; ; Fax: +86 571 8546 3955 ; Tel: +86 571 8648 1960.
Xuwang PanDepartment of Pharmaceutical Preparation , Hangzhou Xixi Hospital , Hangzhou 310023 , Zhejiang Province , China . Email: zhuangrangxiao@sina.com ; Email: zjk0125@yeah.net ; ; Fax: +86 571 8546 3955 ; Tel: +86 571 8648 1960.
Jiankang ZhangDepartment of Pharmaceutical Preparation , Hangzhou Xixi Hospital , Hangzhou 310023 , Zhejiang Province , China . Email: zhuangrangxiao@sina.com ; Email: zjk0125@yeah.net ; ; Fax: +86 571 8546 3955 ; Tel: +86 571 8648 1960.
Rangxiao ZhuangDepartment of Pharmaceutical Preparation , Hangzhou Xixi Hospital , Hangzhou 310023 , Zhejiang Province , China . Email: zhuangrangxiao@sina.com ; Email: zjk0125@yeah.net ; ; Fax: +86 571 8546 3955 ; Tel: +86 571 8648 1960.
Separation Systems (United States) · USHangzhou Xixi hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New anti-hepatocellular injury drugs with better curative effects and fewer side effects are urgently needed at present. In this study, a series of novel

Identifiers

PMID30108739
PMCPMC6072425
OpenAlexW2766894284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.